Novel lncRNA XLOC_032768 alleviates cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-α

Int Immunopharmacol. 2020 Jun:83:106472. doi: 10.1016/j.intimp.2020.106472. Epub 2020 Apr 8.

Abstract

The cellular and molecular mechanisms through which cisplatin induces nephrotoxicity have been investigated extensively. However, the role of long non-coding RNAs (lncRNAs) in cisplatin-induced nephrotoxicity is not well known. We explored the functions and underlying mechanisms of a novel lncRNA XLOC_032768 in cisplatin-induced nephrotoxicity. Cisplatin treatment resulted in the apoptosis of the renal tubular epithelial cells and inflammatory response in a mouse model and human renal proximal tubular epithelial cells (HK-2). The differentially expressed genes (DEGs) of the transcriptome data were determined, and the results showed that lncRNA XLOC_032768 expression was significantly repressed by cisplatin treatment. This result was validated by an RT-qPCR experiment on in vivo and in vitro models. The overexpression of XLOC_032768 significantly inhibited the cisplatin-induced apoptosis and inflammatory response in HK-2 cells and mouse exposed to cisplatin. RNA sequencing analysis further confirmed that XLOC_032768 could regulate tumor necrosis factor (TNF)-α in the cisplatin-induced apoptosis of HK-2 cells in trans-manner. TNF-α inhibition also ameliorated cisplatin-induced apoptosis of renal tubular epithelial cells and renal structural damage. As such, XLOC_032768 suppressed cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-α. LncRNA XLOC_032768 is a potential novel agent to reduce cisplatin-induced nephrotoxicity.

Keywords: Acute kidney injury; Cisplatin; Nephrotoxicity; lncRNA XLOC_032768.

MeSH terms

  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / therapy*
  • Animals
  • Apoptosis
  • Cellobiose / analogs & derivatives
  • Cisplatin / adverse effects*
  • Cisplatin / therapeutic use
  • Drug-Related Side Effects and Adverse Reactions / therapy*
  • Epithelial Cells / physiology*
  • Humans
  • Inflammation / etiology
  • Inflammation / therapy*
  • Kidney Tubules / pathology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • RNA, Long Noncoding / genetics*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • RNA, Long Noncoding
  • Tumor Necrosis Factor-alpha
  • Cellobiose
  • cellobial
  • Cisplatin